title: Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys.
authors.forename: S
authors.initials: S
authors.lastname: Di Fabio
authors.forename: D
authors.initials: D
authors.lastname: Trabattoni
authors.forename: A
authors.initials: A
authors.lastname: Geraci
authors.forename: S
authors.initials: S
authors.lastname: Ruzzante
authors.forename: G
authors.initials: G
authors.lastname: Panzini
authors.forename: M L
authors.initials: ML
authors.lastname: Fusi
authors.forename: F
authors.initials: F
authors.lastname: Chiarotti
authors.forename: F
authors.initials: F
authors.lastname: Corrias
authors.forename: R
authors.initials: R
authors.lastname: Belli
authors.forename: P
authors.initials: P
authors.lastname: Verani
authors.forename: A
authors.initials: A
authors.lastname: Dalgleish
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: F
authors.initials: F
authors.lastname: Titti
mesh_terms: D000284:Administration, Oral; D000818:Animals; D018106:CD28 Antigens / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008252:Macaca fascicularis; D016097:Simian Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000302:isolation & purification*; D013792:Thalidomide / Q000008:administration & dosage*; D019562:Viral Load
chemical_list: D018106:CD28 Antigens; D007166:Immunosuppressive Agents; D013792:Thalidomide